Genus suffers legal setback Stateside
Genus suffered a legal setback Stateside as a US judge handed down a series of verdicts against the animal genetics specialist.
FTSE 250
21,162.71
16:59 19/09/24
FTSE 350
4,600.84
17:09 19/09/24
FTSE All-Share
4,556.59
16:59 19/09/24
Genus
1,908.00p
16:34 19/09/24
Pharmaceuticals & Biotechnology
22,712.68
17:09 19/09/24
The US District Court for Wisconsin ruled that two of Genus rival ST´s patents were valid and had been infringed and that ABS, a unit of Genus, had materially broken its confidentiality obligations as set out in the 2012 semen sorting agreement between the two parties.
The rulings were linked to Genus´s ABS unit´s GSS technology for sexing bovine semen that does not subject the sperm cells to high pressures and forces.
UK-based Genus said it was still awaiting the judge´s decisión on a number of motions related to the provisions of the 2012 agreement and that it would update the market further when the rulings were made.
A verdict on the damages related to those matters would be considered by the jury later this week, Genus said in a statement.